Barber Avenue Biotech Three Gateway Park Graduate Tenant Companies

MBI provides infrastructure support for biotechnology start up companies like EpigenDx.  MBI helps EpigenDx in many different ways, such as staffing support, facility support, and training support.  MBI provides a networking environment among the New England biotech industries.

Liying Yan, President EpigenDX


 


MBI Incubator at Barber Avenue

MBIdeas Barber Avenue: Located at the intersection of Interstate 190 & 290 for easy highway access, this MBI incubator facility houses numerous laboratories (of all sizes), offices and kitchen areas. Shared equipment and cold room are also available for tenant company use. A true spirit of life science entrepreneurial support is the trademark of this lab site which enhances the scientist’s commercialization success.

Tenants at the Barber Avenue Facilities


  • AC PharmaChem, Inc.
    Contact: Lei Zhang, Ph.D., President & CEO
    Email: ACPharmaChem@yahoo.com
    Phone: 1-508-887-0899, 1-508-471-4121
    Fax: 1-508-845-9201, 1-508-471-4121
    100 Barber Avenue Worcester, MA 01606, USA
    Website: http://www.ACPharmaChem.com (under construction)

    AC PharmaChem, Inc. is a fast growing company providing contract research and development services of medicinal chemistry, customer based organic synthesis of special chemical reagents, intermediates, reference compounds, and synthesis of focused libraries. The company's goal is to fully support our pharmaceutical and biotech partners to speed up and advance their drug discovery and innovation processes. At AC PharmaChem, we have experienced medicinal and synthetic chemists utilizing state-of-the-art synthetic techniques and instruments to provide cost efficient and on time delivery to meet the demands of our customers.

  • Attogen Biomedical Research (ABR)
    Contact: X. Jia Chang, President and Chief Scientific Officer
    Email: jia.chang@attogenbio.com
    Phone: 781-330-6438

    Attogen Biomedical Research (ABR) is a division of Attogen Inc, a private biotechnology company. ABR focuses on developing antibody-based technologies for tumor biomarker detection and antibody drug discovery. ABR has proprietary monoclonal antibodies to a tumor metastasis target that is a causative gene for tumor metastasis. The company is developing sensitive diagnostics for this biomarker and evaluating its therapeutic potential for multiple cancer indications.

  • Entegrion, Inc.
    Contact: Keith Rosiello
    Email: keithr@krossengineering.com
    Phone: 508-450-7672
    Fax (Keith): 508-845-8813
    Fax (Main): 919-536-1700

    Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, wound management, and associated tissue repair. The company is based in North Carolina's Research Triangle Park, and is the inventor of StasilonTM the FDA approved hemostatic medical textile technology approved for use both by prescription and by consumers from which multiple hemorrhage control products are made.Building upon technologies licensed from the University of North Carolina, Entegrion's portfolio includes platelet-derived platform technologies that are being developed as topical gels and sprays for tissue repair, infusible hemostatic agents for the control of internal hemorrhage, and novel vehicles for delivery of drugs to targeted tumors and other sites of internal bleeding. For more information, visit Entegrion, Inc.

  • EpigenDX
    Contact: Liying Yan, President
    Email: lyan@epigendx.com
    Phone: 508-904-0805
    Fax: 508-881-6810

    EpigenDx is a genomic and epigenomic research company focusing on biomarker discovery and testing. The company also provides the products and laboratory services for biotechnology community.

  • Hypromatrix, Inc.
    Contact: James Wang, President
    Email: jwang@hypromatrix.com
    Phone: 508-856-7900

    Hypromatrix is a drug discovery and development technology company. It is a leader in developing platform proteomic technology to accelerate and rationalize the process of doing discovery and scientific research.

  • ProFoldin Protein Folding Services
    Contact: John Chen, Scientist
    Email: my_protein@profoldin.com
    Phone: 774-287-3651
    Fax: 508-845-9258

    ProFoldin Protein Folding Services is committed to providing professional services and novel research tools to academic institutes, biotech and pharmaceutical industries in the area of protein sciences. One of the company's focus area is to help our customers to make active proteins from inactive ones, a process called protein folding. ProFoldin provides protein folding columns and reagents and performs customer protein folding services.

  • Technical Innovation Center, Inc.
    Contact: Richard Langevin, CEO
    Email: richard@triz.org
    Phone: 508-799-6700

    Technical Innovation Center, Inc. is a publishing and training company that provides information about TRIZ (Theory of Inventive Problem Solving). We have 3 books on the subject and provide scheduled training. More information about what we do and what we offer is available on our website.

  • Welgen, Inc.
    Contact: Keith Luo, President
    Email: kluo@welgeninc.com
    Phone: 508-791-9966
    Fax: 508-791-9948

    Welgen, Inc. is a biotech company dedicated to developing technologies and products for biomedical research. The company was founded in 2002 to develop vectors for gene delivery and silencing that facilitate research activities in both academia and industry. Our products provide the medical research community and the pharmaceutical industry with rapid and cost-efficient approaches for gene function research and drug development.



 
 
Powered by ARGInteractive.com Copyright © 1997 - 2008 Massachusetts Biomedical Initiatives. All Rights Reserved